DCF — UVA HEALTH PRINCE WILLIAM MEDICAL
Enterprise Value: $-232.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-232.9M
Enterprise Value
$-75.4M
PV of Cash Flows
$-157.4M
PV of Terminal Value
$-253.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $197.4M | $-13.6M | -7.0% | $-21.9M | $-19.9M |
| Year 2 | $203.3M | $-11.9M | -6.0% | $-20.5M | $-17.0M |
| Year 3 | $209.4M | $-10.2M | -5.0% | $-19.1M | $-14.3M |
| Year 4 | $215.7M | $-9.4M | -4.0% | $-18.6M | $-12.7M |
| Year 5 | $222.2M | $-9.1M | -4.0% | $-18.6M | $-11.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-232.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$191.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07367955978749324
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5